Literature DB >> 15798950

Iron loading increases cholesterol accumulation and macrophage scavenger receptor I expression in THP-1 mononuclear phagocytes.

Pavel J Kraml1, Richard L Klein, Yan Huang, Alena Nareika, Maria F Lopes-Virella.   

Abstract

Epidemiological studies have established that a high level of iron body stores is associated with increased risk of acute coronary heart disease. To explain this association, it has been proposed that iron catalyzes the production of highly reactive forms of free oxygen species, and thus, promotes low-density lipoprotein (LDL) oxidation, a lipoprotein that plays a critical role in atherogenesis. However, few studies have provided evidence to support this hypothesis. In the present study, we determined the effect of iron loading of THP-1 mononuclear phagocytes on LDL metabolism. We demonstrated that iron loading of THP-1 cells stimulated conjugated diene formation in LDL in the culture medium. In addition, iron loading of THP-1 cells significantly increased cholesteryl ester accumulation in cells exposed to native LDL, suggesting that during the incubation of the cells with native LDL, the LDL became oxidized and was taken up by the cells. We further demonstrated that the degradation of 125I-oxidized LDL was significantly increased in iron-loaded THP-1 cells. Lastly, we demonstrated that iron loading of THP-1 cells stimulated scavenger receptor expression in these cells. In conclusion, this study demonstrates that loading of mononuclear phagocytes with iron leads to oxidization of LDL, increased cellular cholesterol accumulation and scavenger receptor expression, and supports the hypothesis that increased macrophage iron levels promote atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15798950     DOI: 10.1016/j.metabol.2004.10.012

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  15 in total

Review 1.  Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney disease.

Authors:  Elena Canavesi; Carlo Alfieri; Serena Pelusi; Luca Valenti
Journal:  World J Nephrol       Date:  2012-12-06

2.  Iron sucrose promotes endothelial injury and dysfunction and monocyte adhesion/infiltration.

Authors:  Vaijinath S Kamanna; Shobha H Ganji; Stanislav Shelkovnikov; Keith Norris; Nosratola D Vaziri
Journal:  Am J Nephrol       Date:  2011-12-29       Impact factor: 3.754

Review 3.  The role of hepcidin and iron homeostasis in atherosclerosis.

Authors:  Florian Wunderer; Lisa Traeger; Haakon H Sigurslid; Patrick Meybohm; Donald B Bloch; Rajeev Malhotra
Journal:  Pharmacol Res       Date:  2020-01-25       Impact factor: 7.658

4.  The iron chelator, desferrioxamine, reduces inflammation and atherosclerotic lesion development in experimental mice.

Authors:  Wei-Jian Zhang; Hao Wei; Balz Frei
Journal:  Exp Biol Med (Maywood)       Date:  2010-05

Review 5.  Biometals and their therapeutic implications in Alzheimer's disease.

Authors:  Scott Ayton; Peng Lei; Ashley I Bush
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

6.  The statin-iron nexus: anti-inflammatory intervention for arterial disease prevention.

Authors:  Leo R Zacharski; Ralph G DePalma; Galina Shamayeva; Bruce K Chow
Journal:  Am J Public Health       Date:  2013-02-14       Impact factor: 9.308

Review 7.  Vascular Damage in Patients with Nonalcoholic Fatty Liver Disease: Possible Role of Iron and Ferritin.

Authors:  Giuseppina Pisano; Rosa Lombardi; Anna Ludovica Fracanzani
Journal:  Int J Mol Sci       Date:  2016-05-05       Impact factor: 5.923

Review 8.  Intravenous iron therapy and the cardiovascular system: risks and benefits.

Authors:  Lucia Del Vecchio; Robert Ekart; Charles J Ferro; Jolanta Malyszko; Patrick B Mark; Alberto Ortiz; Pantelis Sarafidis; Jose M Valdivielso; Francesca Mallamaci
Journal:  Clin Kidney J       Date:  2020-11-26

9.  Iron and hepcidin as risk factors in atherosclerosis: what do the genes say?

Authors:  Tessel E Galesloot; Luc L Janss; Stephen Burgess; Lambertus A L M Kiemeney; Martin den Heijer; Jacqueline de Graaf; Suzanne Holewijn; Beben Benyamin; John B Whitfield; Dorine W Swinkels; Sita H Vermeulen
Journal:  BMC Genet       Date:  2015-07-11       Impact factor: 2.797

10.  A delicate balance: Iron metabolism and diseases of the brain.

Authors:  Dominic Hare; Scott Ayton; Ashley Bush; Peng Lei
Journal:  Front Aging Neurosci       Date:  2013-07-18       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.